|
|
Gene Symbol |
PTEN |
|
Aliases |
10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, PTENbeta, TEP1 |
|
Entrez Gene ID |
|
|
Gene Name |
Phosphatase and tensin homolog |
|
Chromosomal Location |
10q23.31 |
|
HGNC ID |
|
|
Summary |
This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000079 |
Biological process |
Regulation of cyclin-dependent protein serine/threonine kinase activity |
TAS |
10918569 |
GO:0001933 |
Biological process |
Negative regulation of protein phosphorylation |
IDA |
20123964 |
GO:0006470 |
Biological process |
Protein dephosphorylation |
IDA |
9256433 |
GO:0006470 |
Biological process |
Protein dephosphorylation |
TAS |
9367992 |
GO:0008283 |
Biological process |
Cell proliferation |
TAS |
10918569 |
GO:0008285 |
Biological process |
Negative regulation of cell proliferation |
IDA |
19057511 |
GO:0008285 |
Biological process |
Negative regulation of cell proliferation |
IMP |
10468583, 17880912 |
GO:0010719 |
Biological process |
Negative regulation of epithelial to mesenchymal transition |
IMP |
27919618 |
GO:0010977 |
Biological process |
Negative regulation of neuron projection development |
ISS |
28008308 |
GO:0014067 |
Biological process |
Negative regulation of phosphatidylinositol 3-kinase signaling |
NAS |
16762633 |
GO:0014067 |
Biological process |
Negative regulation of phosphatidylinositol 3-kinase signaling |
TAS |
18082964 |
GO:0030336 |
Biological process |
Negative regulation of cell migration |
IMP |
9616126, 17880912, 21573166 |
GO:0031647 |
Biological process |
Regulation of protein stability |
IMP |
10866658 |
GO:0045736 |
Biological process |
Negative regulation of cyclin-dependent protein serine/threonine kinase activity |
IDA |
21241890 |
GO:0046855 |
Biological process |
Inositol phosphate dephosphorylation |
IDA |
9593664 |
GO:0046856 |
Biological process |
Phosphatidylinositol dephosphorylation |
IDA |
9593664, 9811831 |
GO:0046856 |
Biological process |
Phosphatidylinositol dephosphorylation |
IMP |
21828076 |
GO:0050821 |
Biological process |
Protein stabilization |
IDA |
20123964 |
GO:0051091 |
Biological process |
Positive regulation of DNA-binding transcription factor activity |
IMP |
20123964 |
GO:0051548 |
Biological process |
Negative regulation of keratinocyte migration |
IMP |
27919618 |
GO:0051895 |
Biological process |
Negative regulation of focal adhesion assembly |
IMP |
9616126 |
GO:0051898 |
Biological process |
Negative regulation of protein kinase B signaling |
IMP |
10760291, 19962668, 21573166, 22879939, 26280536 |
GO:0060070 |
Biological process |
Canonical Wnt signaling pathway |
IDA |
20123964 |
GO:0070373 |
Biological process |
Negative regulation of ERK1 and ERK2 cascade |
IMP |
19962668 |
GO:0071257 |
Biological process |
Cellular response to electrical stimulus |
IMP |
27919618 |
GO:1903690 |
Biological process |
Negative regulation of wound healing, spreading of epidermal cells |
IMP |
27919618 |
GO:1903984 |
Biological process |
Positive regulation of TRAIL-activated apoptotic signaling pathway |
IMP |
19962668 |
GO:1904668 |
Biological process |
Positive regulation of ubiquitin protein ligase activity |
IDA |
21241890 |
GO:1904706 |
Biological process |
Negative regulation of vascular smooth muscle cell proliferation |
IMP |
26208095 |
GO:2000060 |
Biological process |
Positive regulation of ubiquitin-dependent protein catabolic process |
IDA |
21241890 |
GO:2000134 |
Biological process |
Negative regulation of G1/S transition of mitotic cell cycle |
IDA |
21241890 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
17218261, 21241890, 24862762 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
9187108, 10760291, 10940933, 21241890, 24862762 |
GO:0005737 |
Cellular component |
Cytoplasm |
TAS |
9367992 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
10760291 |
GO:0009898 |
Cellular component |
Cytoplasmic side of plasma membrane |
IDA |
10940933 |
GO:0016324 |
Cellular component |
Apical plasma membrane |
IMP |
24862762 |
GO:0042995 |
Cellular component |
Cell projection |
IDA |
10760291, 25007873 |
GO:0004438 |
Molecular function |
Phosphatidylinositol-3-phosphatase activity |
IDA |
9811831 |
GO:0004721 |
Molecular function |
Phosphoprotein phosphatase activity |
IDA |
21241890 |
GO:0004722 |
Molecular function |
Protein serine/threonine phosphatase activity |
IDA |
9256433 |
GO:0004725 |
Molecular function |
Protein tyrosine phosphatase activity |
IDA |
9256433 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
15355975, 15951562, 16456542, 17242191, 17274640, 19345329, 19369943, 19473982, 19903340, 21241890, 21804599, 23514585, 23940795, 24012959, 24656772, 25007873, 25241761 |
GO:0010997 |
Molecular function |
Anaphase-promoting complex binding |
IPI |
21241890 |
GO:0016314 |
Molecular function |
Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity |
IDA |
9593664, 9811831 |
GO:0019899 |
Molecular function |
Enzyme binding |
IPI |
16845383 |
GO:0030165 |
Molecular function |
PDZ domain binding |
IPI |
10646847, 10760291 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
24766807 |
GO:0051717 |
Molecular function |
Inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity |
IDA |
9593664 |
GO:0051800 |
Molecular function |
Phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity |
IDA |
9811831 |
GO:1990381 |
Molecular function |
Ubiquitin-specific protease binding |
IPI |
26280536 |
|
Protein Information |
|
Protein Name |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, MMAC1 phosphatase and tensin homolog deleted on chromosome 10, mitochondrial PTENalpha, mitochondrial phosphatase and tensin protein alpha, mutated in multiple advanced cancers 1, phosphatase and tensin-like protein, phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, protein tyrosine phosphatase |
|
Function |
Tumor suppressor. Acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins. Also acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-tetrakisphosphate with order of substrate preference in vitro PtdIns(3,4,5)P3 > PtdIns(3,4)P2 > PtdIns3P > Ins(1,3,4,5)P4 (PubMed:26504226, PubMed:16824732). The lipid phosphatase activity is critical for its tumor suppressor function. Antagonizes the PI3K-AKT/PKB signaling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival. The unphosphorylated form cooperates with AIP1 to suppress AKT1 activation. Dephosphorylates tyrosine-phosphorylated focal adhesion kinase and inhibits cell migration and integrin-mediated cell spreading and focal adhesion formation. Plays a role as a key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. May be a negative regulator of insulin signaling and glucose metabolism in adipose tissue. The nuclear monoubiquitinated form possesses greater apoptotic potential, whereas the cytoplasmic nonubiquitinated form induces less tumor suppressive ability. In motile cells, suppresses the formation of lateral pseudopods and thereby promotes cell polarization and directed movement. .; [Isoform alpha]: Functional kinase, like isoform 1 it antagonizes the PI3K-AKT/PKB signaling pathway. Plays a role in mitochondrial energetic metabolism by promoting COX activity and ATP production, via collaboration with isoform 1 in increasing protein levels of PINK1 |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000260356 |
P07996 |
P07996 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Hypertensive disease |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Genetic Diseases |
12844284, 15805158, 25022750, 19668082, 17427195, 25132236, 11238682, 17392703, 17286265, 24136893, 19265751, 23695273, 21194675, 22252256 |
Language Development Disorder |
|
Macrocephaly/autism syndrome |
15805158, 26637798, 23160955, 27426521, 21956414, 9832032, 25741868, 23470840, 25525159, 9399897, 26443266, 23695273, 26633545, 25326637, 10749983, 24088041, 24778394, 21659347, 28086757, 23475934 |
Long QT Syndrome |
|
Multiple congenital anomalies |
|
LEOPARD Syndrome |
|
Polydactyly |
|
Digestive System Diseases |
Fatty Liver |
|
Endocrine System Diseases |
PCOS |
|
Eye Diseases |
Anisometropia |
|
Musculoskeletal Diseases |
Radial Club Hand |
|
Neoplasms |
Lhermitte-Duclos disease |
19968660, 17427195, 11685670, 9140396, 11748304, 9286463, 10400993, 9259288, 11496368, 10353779, 9241266, 14574156, 19321504, 9467011, 15355975, 9797362, 18716620, 10051160, 9832031, 11494117, 11230179, 9425889, 9915974, 9345101, 10234502, 9616126, 9811831, 10866302 |
Heriditary Neoplastic Syndrome |
26787237, 11886535, 24375884, 17942903, 17218260, 17526800, 22266152, 25669429, 10232405, 10076877, 9399897, 10923032, 22327138, 9425889, 25851949, 17043057, 10555148, 20712882, 16704655, 20300775, 21194675, 17324556, 16894538, 17941496, 28286253, 24778394, 15372512, 22252256, 24102 |
Prostate cancer |
22610119, 21456062, 29610475, 29335545, 19396168, 20729295, 21714127, 17173048, 16421604, 23248098, 19081794, 22581815, 28319090, 9371490, 26504226, 9072974 |
Endometrial Cancer |
|
PTEN Hamartoma Tumor Syndrome |
11496368, 14574156, 9286463, 10400993, 19968660, 19321504, 9140396, 9259288, 11685670, 9241266, 11748304, 10353779, 17427195, 9399897, 9811831, 18716620, 9345101, 9600246, 9797362, 9425889, 10051160, 10866302, 9735393, 9832031, 9467011, 10234502, 15355975, 11494117, 9616126, 23934111, 17392703, 25669429, 24033266, 24379037, 23335809, 26362251, 26681312, 25527629, 21956414, 27477328, 16752378, 28492532, 21659347, 21828076, 21194575, 20926450, 16773562, 9288766, 17526800, 11052475, 16021145, 11071384, 23475934 |
Lipomatosis |
|
Adenocarcinoma |
|
Lung Cancer |
20018398, 19351834, 20085938, 9598803, 10555148, 20881644, 11504908, 17909629, 27980214, 26619011, 22941188 |
Meningioma |
|
Ovarian Cancer |
|
Nasopharyngeal Cancer |
|
Pancreatic Neoplasm |
|
Carcinoma |
|
Cerebellar Granule Cell Hypertrophy and Megalencephaly |
9259288, 15355975, 10866302, 9399897, 10051160, 9735393, 9140396, 9600246, 10234502, 11494117, 9467011, 9915974, 9345101, 9811831, 9797362, 9832031, 9616126, 9425889, 18716620, 11230179 |
Brain Neoplasms |
|
Glioma |
|
Proteus Syndrome |
11748304, 12471211, 17427195, 9140396, 9345101, 11230179, 9399897, 15355975, 18716620, 9425889, 10234502, 9600246, 10866302, 9616126, 11494117, 9259288, 9735393, 10051160, 9811831, 9797362, 9467011, 9832031, 9915974, 14518070, 17392703, 10749983, 10353779 |
Cribriform Carcinoma |
|
Colorectal Cancer |
15254419, 20619739, 19366826, 26619011, 18725974, 22162589, 19903786, 22162582, 15016963, 20453058, 15647370 |
Cerebelloparenchymal Disorder VI |
10234502, 9616126, 9600246, 9467011, 9915974, 11230179, 15355975, 10866302, 9399897, 9345101, 9259288, 9832031, 18716620, 9425889, 9735393, 9140396, 9797362, 11494117, 10051160, 9811831 |
Prostatic Intraepithelial Neoplasias |
|
Bannayan-Riley-Ruvalcaba Syndrome |
10400993, 14574156, 11748304, 17427195, 19968660, 9259288, 19321504, 11496368, 9286463, 9140396, 9241266, 11685670, 10353779, 9467011, 11494117, 25326637 |
Adenoid Cystic Carcinoma |
|
Breast Cancer |
|
Glioblastoma |
|
Hemangioma |
|
Head Neoplasms |
|
Adenoma |
|
Lymphoma |
|
Intrahepatic Cholangiocarcinoma |
|
Hibernoma |
|
Lipoma |
|
Extrahepatic Cholangiocarcinoma |
|
Renal Cancer |
|
Chorioangioma |
|
Liver Cancer |
|
Thyroid Cancer |
|
Mouth Neoplasms |
|
Gastrointestinal Cancer |
|
Adenocarcinoma of Prostate |
|
Angioma |
|
Cholangiocarcinoma |
|
Gastric Cancer |
|
Bladder Cancer |
|
Ctaneous Melanoma |
|
Leukemia |
|
Anaplastic Carcinoma |
|
Vulvar Cancer |
|
Nervous System Diseases |
Hydrocephalus |
|
VACTERL Association |
|
Psychiatric/Brain disorders |
Autistic Disorder |
|
Intellectual Disability |
|
Neurodevelopmental Disorders |
|
Central Auditory Processing Disorder |
|
Semantic-Pragmatic Disorder |
|
Child Development Deviations |
|
Motor Skills Disorders |
|
Developmental Disabilities |
|
Reproductive disorders |
Endometrial Hyperplasia |
|
Preeclampsia |
|
Respiratory Tract Diseases |
Asthma |
|
Skin and Connective Tissue Diseases |
Dermatitis |
|
Lipomatosis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
IGF1, IGFBP1 |
PCOS, endometrial cancer |
|
Rotterdam European Society for Human Reproduction and Embryology (ESHRE) and the American Society of Reproductive Medicine (ASRM) criteria |
Related
|
102 participants: 34 PCOS, 34 EC and 34 control. |
Women with PCOS and EC have an increased endometrial expression of genes (IGF1, IGFBP1 and PTEN) involved in the insulin signalling pathway compared with control women. This may explain the increased risk of EC in PCOS women. |
|
|
|
|